APP and neuroblastoma: In vivo, continuous intracerebral infusion of exogenous neuroblastoma-produced EVs apparently trapped and targeted for microglial phagocytosis sufficient Aβ in the brain of APP overexpressing transgenic mice to reduce Aβ levels, amyloid deposition, and synaptotoxicity in the hippocampus (Yuyama et al., 2014).